Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

MEK1/2

MEK1/2, also known as MAPKK (mitogen-activated protein kinase kinase), is a kinase enzyme which phosphorylates MAPK (mitogen-activated protein kinase).

Items 1-10 of 13

Page
per page
  1. PD184352 (CI-1040)
    A1792 PD184352 (CI-1040)
    Target: MEK
    Summary: Selective MEK inhibitor
      ≥47.9 mg/mL
  2. U0126-EtOH
    A1337 U0126-EtOH
     10 Citation
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.33 mg/mL
  3. Pimasertib (AS-703026)
    A5573 Pimasertib (AS-703026)
    Target: MEK
    Summary: MEK1/2 inhibitor
      ≥21.55 mg/mL
  4. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: Selective MEK5 inhibitor
      ≥22.05 mg/mL
  5. MEK162 (ARRY-162, ARRY-438162)
    A1947 MEK162 (ARRY-162, ARRY-438162)
    Target: MEK
    Summary: MEK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  6. AZD8330
    A8374 AZD8330
    Target: MEK
    Summary: MEK 1/2 inhibitor
      ≥23.05 mg/mL
  7. TAK-733
    B1621 TAK-733
    Target: MEK
    Summary: MEK allosteric site inhibitor
      ≥25.2 mg/mL
  8. Refametinib
    B1267 Refametinib
    Target: MEK
    Summary: MEK 1/ MEK 2 inhibitor
      insoluble in H2O; ≥151.8 mg/mL
  9. GDC-0623
    B1135 GDC-0623
    Target: MEK
    Summary: MEK1 inhibitor, potent and ATP-uncompetitive
      insoluble in H2O; ≥16.85 mg/mL
  10. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL

Items 1-10 of 13

Page
per page
Relate Categories
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
  3. Related Disease Cancer Remove This Item
Clear All